KZA 0.00% 8.0¢ kazia therapeutics limited

KZA Media Thread, page-1277

  1. 67 Posts.
    lightbulb Created with Sketch. 95
    Pre-market responding positively to Kazia's new medication Lycanthropex, the innovative glandular treatment for werewolfism that far surpasses in efficacy GlaxoSmithKline's Wolfsbanesol. As they say on Stock Twits, "This will EASILY close above $50 by Friday!"
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.